CLAIRE SENECAL: Open Payments
NPI 1588366058 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $379 · 2025 $464
Food & beverage: $376Education: $88
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $123 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Organon LLC | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $46 |
| MILLICENT US INC | 2 | $40 |
| Exeltis, USA Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: NEXPLANON, INJECTAFER, Veozah, MYFEMBREE, SLYND, INTERSTIM, Wegovy, Lynkuet.
Industry payments across VA — which companies pay providers there.
